White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry).

White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry). Circ Cardiovasc Interv. 2017 Sep; 10(9).

View in: PubMed

subject areas

Acute Coronary Syndrome
Acute Coronary Syndrome
Aged
Aged
Coronary Artery Disease
Coronary Artery Disease
Coronary Thrombosis
Coronary Thrombosis
Drug Therapy, Combination
Drug Therapy, Combination
Europe
Europe
Female
Female
Humans
Humans
Kaplan-Meier Estimate
Kaplan-Meier Estimate
Leukocyte Count
Leukocyte Count
Leukocytes
Leukocytes
Male
Male
Medication Adherence
Medication Adherence
Middle Aged
Middle Aged
Multivariate Analysis
Multivariate Analysis
Myocardial Infarction
Myocardial Infarction
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Predictive Value of Tests
Predictive Value of Tests
Proportional Hazards Models
Proportional Hazards Models
Prospective Studies
Prospective Studies
Registries
Registries
Retreatment
Retreatment
Risk Factors
Risk Factors
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
United States
United States

authors with profiles

Usman Baber